Anti-GD2 CAR T Cells Could Prove Transformative for H3-K27M Diffuse Midline Gliomas

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35117070

Authors

Koichi Furukawa

Yuhsuke Ohmi

Keiko Furukawa

Affiliations

Soon will be listed here.

Citing Articles

Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma-Recent Advances.

Kowalczyk A, Zarychta J, Marszolek A, Zawitkowska J, Lejman M Cancers (Basel). 2024; 16(3).

PMID: 38339374 PMC: 10854514. DOI: 10.3390/cancers16030623.

Erratum to anti-GD2 CAR T cells could prove transformative for H3-K27M diffuse midline gliomas.

Furukawa K, Ohmi Y, Furukawa K Transl Cancer Res. 2022; 8(3):1014-1015.

PMID: 35129554 PMC: 8798005. DOI: 10.21037/tcr.2019.04.17.

References

Watanabe T, Pukel C, Takeyama H, LLOYD K, Shiku H, Li L . Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med. 1982; 156(6):1884-9. PMC: 2186856. DOI: 10.1084/jem.156.6.1884. View

Battula V, Shi Y, Evans K, Wang R, Spaeth E, Jacamo R . Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest. 2012; 122(6):2066-78. PMC: 3591166. DOI: 10.1172/JCI59735. View

Villanueva-Cabello T, Mollicone R, Cruz-Munoz M, Lopez-Guerrero D, Martinez-Duncker I . Activation of human naïve Th cells increases surface expression of GD3 and induces neoexpression of GD2 that colocalize with TCR clusters. Glycobiology. 2015; 25(12):1454-64. DOI: 10.1093/glycob/cwv062. View

Esaki N, Ohkawa Y, Hashimoto N, Tsuda Y, Ohmi Y, Bhuiyan R . ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer. Cancer Sci. 2017; 109(1):141-153. PMC: 5765286. DOI: 10.1111/cas.13448. View

Blackhall F, Shepherd F . Small cell lung cancer and targeted therapies. Curr Opin Oncol. 2007; 19(2):103-8. DOI: 10.1097/CCO.0b013e328011bec3. View

Nagata Y, Yamashiro S, Yodoi J, LLOYD K, Shiku H, Furukawa K . Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. J Biol Chem. 1992; 267(17):12082-9. View

Takamiya K, Yamamoto A, Yamashiro S, Shin M, Okada M, Fukumoto S . Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A. 1996; 93(20):10662-7. PMC: 38211. DOI: 10.1073/pnas.93.20.10662. View

Hamamura K, Furukawa K, Hayashi T, Hattori T, Nakano J, Nakashima H . Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci U S A. 2005; 102(31):11041-6. PMC: 1180226. DOI: 10.1073/pnas.0503658102. View

Kaneko K, Ohkawa Y, Hashimoto N, Ohmi Y, Kotani N, Honke K . Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells. J Biol Chem. 2016; 291(32):16630-43. PMC: 4974378. DOI: 10.1074/jbc.M115.708834. View

10.

Yoshida S, Fukumoto S, Kawaguchi H, Sato S, Ueda R, Furukawa K . Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 2001; 61(10):4244-52. View

11.

Ahmed M, Cheung N . Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy. FEBS Lett. 2013; 588(2):288-97. DOI: 10.1016/j.febslet.2013.11.030. View

12.

Thurin J, Thurin M, Herlyn M, Elder D, Steplewski Z, Clark Jr W . GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression. FEBS Lett. 1986; 208(1):17-22. DOI: 10.1016/0014-5793(86)81522-8. View

13.

Aixinjueluo W, Furukawa K, Zhang Q, Hamamura K, Tokuda N, Yoshida S . Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis. J Biol Chem. 2005; 280(33):29828-36. DOI: 10.1074/jbc.M414041200. View

14.

Kotani N, Gu J, Isaji T, Udaka K, Taniguchi N, Honke K . Biochemical visualization of cell surface molecular clustering in living cells. Proc Natl Acad Sci U S A. 2008; 105(21):7405-9. PMC: 2396715. DOI: 10.1073/pnas.0710346105. View

15.

Simons K, Ikonen E . Functional rafts in cell membranes. Nature. 1997; 387(6633):569-72. DOI: 10.1038/42408. View

16.

Akagi T, Nagata Y, Yamada Y, Shimotohno K, Cheung N, Shiku H . GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax. Proc Natl Acad Sci U S A. 1993; 90(5):1972-6. PMC: 46002. DOI: 10.1073/pnas.90.5.1972. View

17.

Okada M, Yamashiro S, Yamada Y, Haraguchi M, Horibe K, Kato K . High expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I. Cancer Res. 1996; 56(12):2844-8. View

18.

Wu G, Diaz A, Paugh B, Rankin S, Ju B, Li Y . The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet. 2014; 46(5):444-450. PMC: 4056452. DOI: 10.1038/ng.2938. View

19.

Suzuki K . The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation. J Neurochem. 1965; 12(7):629-38. DOI: 10.1111/j.1471-4159.1965.tb04256.x. View

20.

Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H . Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. Cancer Res. 2009; 69(23):9003-11. DOI: 10.1158/0008-5472.CAN-09-1450. View